» Articles » PMID: 9028448

Increased Low-level Chromosome 21 Mosaicism in Older Individuals with Down Syndrome

Overview
Journal Am J Med Genet
Specialty Genetics
Date 1997 Jan 20
PMID 9028448
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

During a study of the familial aggregation of Down syndrome (DS) and Alzheimer disease (AD), we observed an increase in mosaicism for disomy 21 in older individuals with DS. In a total of 213 DS subjects who were studied cytogenetically, only 1 of 121 (0.8%) under age 45 exhibited mosaicism, while 14 of 92 (15.2%) who were age 45 or older had mosaicism. Mosaicism in this report connotes "low-level" mosaicism, where all 15 individuals exhibited a modal chromosome number of 47 (i.e., trisomy 21), and at least two cells lacked one of the three chromosomes 21. The occurrence of aneuploidy for chromosomes 15, 17, and X increased with age, and an inverse correlation between chromosome loss and size was also observed. Because older individuals had not been karyotyped at birth, it was not possible to determine whether our observations were due to either increased survival of mosaic individuals or accumulation of disomy 21 cells via increased chromosome loss with aging of the trisomy 21 individual. Using a modeling approach involving life table methods, we obtained results that suggested acquired mosaicism as the predominant mechanism to explain our findings. These results support the hypothesis that as individuals with DS age, there is an increased loss of chromosome 21.

Citing Articles

A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology.

Liou J, Lou J, Flores-Aguilar L, Nakagiri J, Yong W, Hom C Alzheimers Dement. 2025; 21(2):e14479.

PMID: 39868632 PMC: 11851131. DOI: 10.1002/alz.14479.


Trisomy 21-associated increases in chromosomal instability are unmasked by comparing isogenic trisomic/disomic leukocytes from people with mosaic Down syndrome.

Rafferty K, Archer K, Turner K, Brown R, Jackson-Cook C PLoS One. 2021; 16(7):e0254806.

PMID: 34283872 PMC: 8291705. DOI: 10.1371/journal.pone.0254806.


Beyond Trisomy 21: Phenotypic Variability in People with Down Syndrome Explained by Further Chromosome Mis-segregation and Mosaic Aneuploidy.

Potter H J Down Syndr Chromosom Abnorm. 2018; 2(1).

PMID: 29516054 PMC: 5837063. DOI: 10.4172/2472-1115.1000109.


Down syndrome, beta-amyloid and neuroimaging.

Head E, Helman A, Powell D, Schmitt F Free Radic Biol Med. 2017; 114:102-109.

PMID: 28935420 PMC: 5748259. DOI: 10.1016/j.freeradbiomed.2017.09.013.


Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.

Doran E, Keator D, Head E, Phelan M, Kim R, Totoiu M J Alzheimers Dis. 2016; 56(2):459-470.

PMID: 27983553 PMC: 5662115. DOI: 10.3233/JAD-160836.